| Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant F Zuo, H Abolhassani, L Du, A Piralla, F Bertoglio, L de Campos-Mata, ... Nature Communications 13 (1), 1-8, 2022 | 133 | 2022 |
| Immunity to SARS-CoV-2 up to 15 months after infection H Marcotte, A Piralla, F Zuo, L Du, I Cassaniti, H Wan, M Kumagai-Braesh, ... Iscience, 103743, 2022 | 54 | 2022 |
| X-linked TLR7 deficiency underlies critical COVID-19 pneumonia in a male patient with ataxia-telangiectasia H Abolhassani, A Vosughimotlagh, T Asano, N Landegren, B Boisson, ... Journal of clinical immunology 42 (1), 1-9, 2022 | 42 | 2022 |
| SARS-CoV-2–specific B-and T-cell immunity in a population-based study of young Swedish adults S Björkander, L Du, F Zuo, S Ekström, Y Wang, H Wan, N Sherina, ... Journal of Allergy and Clinical Immunology 149 (1), 65-75. e8, 2022 | 34 | 2022 |
| Hallmarks of Cancers: Primary Antibody Deficiency Versus Other Inborn Errors of Immunity H Abolhassani, Y Wang, L Hammarström, Q Pan-Hammarström Frontiers in Immunology 12, 2021 | 17 | 2021 |
| Genomic characterization of lymphomas in patients with inborn errors of immunity X Ye, PJ Maglione, C Wehr, X Li, Y Wang, H Abolhassani, E Deripapa, ... Blood Advances, 2022 | 15 | 2022 |
| Heterologous inactivated virus/mRNA vaccination response to BF. 7, BQ. 1.1, and XBB. 1 F Zuo, R Sun, H Abolhassani, L Du, Y Wang, S Vlachiotis, F Bertoglio, ... The Lancet Regional Health–Western Pacific 33, 2023 | 6 | 2023 |
| Updates of cancer hallmarks in patients with inborn errors of immunity Y Wang, H Abolhassani Current Opinion in Allergy and Clinical Immunology, 10.1097, 2022 | 4 | 2022 |
| SARS-CoV-2 infection in patients with inborn errors of immunity due to DNA repair defects Y Wang, H Abolhassani, L Hammarström, Q Pan-Hammarström Acta biochimica et biophysica Sinica, 0 | 4 | |
| Cellular mechanisms and clinical applications for phenocopies of inborn errors of immunity: infectious susceptibility due to cytokine autoantibodies R Sun, Y Wang, H Abolhassani Expert Review of Clinical Immunology, 2023 | 1 | 2023 |
| Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of Immunity S Delavari, Y Wang, S Pashangzadeh, F Nazari, F Salami, H Abolhassani Cancers 15 (3), 764, 2023 | | 2023 |
| Heterologous immunization with inactivated vaccine followed by mRNA booster elicits strong humoral and cellular immune responses against the SARS-CoV-2 Omicron variant F Zuo, H Abolhassani, L Du, A Piralla, F Bertoglio, L de Campos-Mata, ... medRxiv, 2022 | | 2022 |
